Unlock 5.0 in Karnataka | Colleges to reopen from November 17: Deputy CM

Karnataka's deputy chief minister said engineering, diploma, postgraduate and graduate colleges will be reopened first starting from November 17. But, students will be given the option to continue to attend classes online.

Moneycontrol News

October 23, 2020 / 20:25 IST

Karnataka will reopen colleges from November 17, after having kept them shut since March, amid the novel coronavirus pandemic.

The development was confirmed by the state’s Deputy Chief Minister and Minister of Higher Education CN Ashwath Narayan after his meeting with the Chief Minister BS Yediyurappa.

However, students will be given the option to continue to attend classes online. “The government has decided to start graduate colleges from November 17. Students will be given the opportunity to learn online or attend offline classes. Students who opt to attend classes must bring a letter of permission from their parents,” Narayan said.

The deputy chief minister added that engineering, diploma, postgraduate and graduate colleges will be reopened first.

In its guidelines for ‘Unlock 5.0’, the Centre had permitted states and Union Territories to decide if they want to reopen educational institutions outside containment zones from October 15. Multiple states have allowed graded reopening of schools.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show